Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank O'Brien

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
European Urology|February 12, 2009
Editorial comment on: current applications for prostate-specific antigen doubling timeMatthew Frank O'Brien
Nature Clinical Practice. Urology|May 24, 2007
Can PSA velocity predict risk of death in men with prostate cancer?Hans Lilja, Frank O'Brien
CEN Case Reports|April 9, 2024
Retraction Note: Anaphylaxis secondary to citric acid allergy in End Stage Renal Disease patientHassaan Iftikhar, Maryam Saleem, Frank O'Brien
CEN Case Reports|July 27, 2023
Anaphylaxis secondary to citric acid allergy in End Stage Renal Disease patientHassaan Iftikhar, Maryam Saleem, Frank O'Brien
European Urology|February 5, 2008
Serum markers for prostate cancer: a rational approach to the literatureThomas Steuber, Matthew Frank O'Brien, Hans Lilja
Journal of Surgical Case Reports|October 27, 2022
Nutcracker syndrome, conservative approach: a case reportMuheilan Muheilan, Anna Walsh, Frank O'Brien, et al.
IJU Case Reports|November 6, 2023
An incidental finding of large cell calcifying Sertoli cell tumor in an orchidectomy specimen for a separate adenomatoid tumorLauren Crone, Sophie C Prendergast, Nick Mayer, et al.
Nature Reviews. Urology|July 7, 2009
Prostate kallikrein markers in diagnosis, risk stratification and prognosisDavid Ulmert, M Frank O'Brien, Anders S Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
BJU International|August 27, 2010
Update on the management of T1 renal cortical tumoursMark L Cutress, Hari L Ratan, Simon T Williams, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
European Urology|February 12, 2009
Editorial comment on: current applications for prostate-specific antigen doubling timeMatthew Frank O'Brien
Nature Clinical Practice. Urology|May 24, 2007
Can PSA velocity predict risk of death in men with prostate cancer?Hans Lilja, Frank O'Brien
CEN Case Reports|April 9, 2024
Retraction Note: Anaphylaxis secondary to citric acid allergy in End Stage Renal Disease patientHassaan Iftikhar, Maryam Saleem, Frank O'Brien
CEN Case Reports|July 27, 2023
Anaphylaxis secondary to citric acid allergy in End Stage Renal Disease patientHassaan Iftikhar, Maryam Saleem, Frank O'Brien
European Urology|February 5, 2008
Serum markers for prostate cancer: a rational approach to the literatureThomas Steuber, Matthew Frank O'Brien, Hans Lilja
Journal of Surgical Case Reports|October 27, 2022
Nutcracker syndrome, conservative approach: a case reportMuheilan Muheilan, Anna Walsh, Frank O'Brien, et al.
IJU Case Reports|November 6, 2023
An incidental finding of large cell calcifying Sertoli cell tumor in an orchidectomy specimen for a separate adenomatoid tumorLauren Crone, Sophie C Prendergast, Nick Mayer, et al.
Nature Reviews. Urology|July 7, 2009
Prostate kallikrein markers in diagnosis, risk stratification and prognosisDavid Ulmert, M Frank O'Brien, Anders S Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
BJU International|August 27, 2010
Update on the management of T1 renal cortical tumoursMark L Cutress, Hari L Ratan, Simon T Williams, et al.
Pageof 3